Mirum Pharmaceuticals (MIRM) Long-Term Investments (2019 - 2026)

Mirum Pharmaceuticals' Long-Term Investments history runs 6 years deep, the most recent figure standing at $34.4 million for Q1 2026.

• In Q1 2026, Long-Term Investments rose 64.27% year-over-year to $34.4 million; the TTM figure through Mar 2026 stood at $34.4 million (up 64.27% YoY), while the FY2025 annual figure was $8.1 million, down 35.29% from the prior year.
• Long-Term Investments for Q1 2026 stood at $34.4 million, up from $8.1 million in the prior quarter.
• The five-year high for Long-Term Investments was $34.4 million in Q1 2026, with the low at $2.5 million in Q3 2025.
• The 3-year median for Long-Term Investments is $14.8 million (2024), against an average of $15.2 million.
• The sharpest annual moves came in 2025 and 2026: Long-Term Investments tumbled 73.5% in 2025, then jumped 64.27% in 2026.
• Mirum Pharmaceuticals' Long-Term Investments stood at $12.5 million in 2024, then plunged by 35.29% to $8.1 million in 2025, then jumped by 323.85% to $34.4 million in 2026.
• Business Quant data shows MIRM's Long-Term Investments at $34.4 million in Q1 2026, $8.1 million in Q4 2025, and $2.5 million in Q3 2025.